Point Nemo Capital, LLC

Position in EXEL — Exelixis, Inc.

CIK 1988307 DRIPPING SPRINGS, TX

Position in EXEL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,022,635

+$238,049 QoQ

Shares Held

18,795

+2.7% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

#336

of 751 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Point Nemo Capital, LLC holds $2,530,821 across 4 Biotechnology names. EXEL ranks #2 (40.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	13,296	$1,507,234
2	EXEL	Exelixis, Inc. This page	18,795	$1,022,635
3	HALO	Halozyme Therapeutics, Inc.	12	$939
4	ELOX	Eloxx Pharmaceuticals, Inc.	1	$13

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,022,635	18,795	+2.7%	Shares	Sole	2026-08-07
2026-03-31	$784,586	18,293	+19.7%	Shares	Sole	2026-05-15
2025-12-31	$670,029	15,287	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.